| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 86,312 | 92,742 | 91,894 | 98,781 | | Cost of Revenue | 75,145 | 81,445 | 82,014 | 85,664 | | | Gross Profit | 11,167 | 11,297 | 9,880 | 13,117 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,826 | 4,948 | 5,845 | 5,145 | | Non Recurring | 151 | 450 | 743 | 84,554 | | Others | 4,241 | 4,293 | 4,080 | 4,065 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,949 | 1,606 | (788) | (80,647) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 37 | (13) | (14) | (376) | | Earnings Before Interest And Taxes | 670 | 1,593 | (802) | (81,023) | | Interest Expense | (847) | 469 | 378 | 479 | | Income Before Tax | 1,517 | 1,124 | (1,180) | (81,502) | | Income Tax Expense | 205 | (64) | (36) | (8,056) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,312 | 1,188 | (1,144) | (73,446) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,312 | 1,188 | (1,144) | (73,446) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,312 | $1,188 | ($1,144) | ($73,446) |
|
0.02% Nasdaq 
Income Statement
